₹ 121200
₹96- ₹101
1200
₹79
-22
16 May 2025
Download20 May 2025
21 May 2025
Application Details
Accretion Pharmaceuticals IPO is a bookbuilding of ₹29.75 crores. The issue is entirely a fresh issue of 29.46 lakh shares.
Accretion Pharmaceuticals IPO bidding opened for subscription on May 14, 2025 and will close on May 16, 2025. The allotment for the Accretion Pharmaceuticals IPO is expected to be finalized on Monday, May 19, 2025. Accretion Pharmaceuticals IPO will be list on NSE SME with a tentative listing date fixed as Wednesday, May 21, 2025.
Accretion Pharmaceuticals IPO price band is set at ₹96 to ₹101 per share. The minimum lot size for an application is 1200. The minimum amount of investment required by retail investors is ₹1,15,200. But it is suggested to the investor to bid at the cutoff price to avoid the oversubscription senerio, which is about to ₹1,21,200. The minimum lot size investment for HNI is 2 lots (2,400 shares) amounting to ₹2,42,400.
About Accretion Pharmaceuticals Limited (SME IPO)
Incorporated in 2012, Accretion Pharmaceuticals Limited is a pharmaceutical company engaged in the manufacturing and marketing of a wide range of healthcare products, including tablets, capsules, and various formulations. The company also provides contract manufacturing services, catering to diverse healthcare segments with its robust infrastructure and expertise.
Accretion’s product portfolio spans tablets, capsules, oral liquids, and syrups, as well as external preparations like ointments, creams, gels, lotions, medicated shampoos, mouthwashes, and dusting powders. Additionally, it manufactures oral powders such as sachets and dry syrups. The company’s offerings also include a line of Ayurvedic and herbal products aimed at supporting immunity, digestion, and overall wellness.
The company’s state-of-the-art manufacturing facility is located in Sanand, Ahmedabad, Gujarat. It operates under strict quality and environmental standards, as evidenced by its ISO 9001:2015, ISO 14001:2015, and ISO 22000:2005 certifications.
Accretion Pharmaceuticals has steadily expanded its global presence and currently exports to more than 20 countries across Africa, Southeast Asia, and the Middle East. Its diverse range of formulations covers critical therapeutic areas such as antibiotics, anti-inflammatory treatments, pain management, cardiovascular health, gastrointestinal care, respiratory conditions, pediatric medicine, and dermatological applications.
FAQ
IPO stands for "Initial Public Offering." It's the process through which a privately-held company becomes publicly traded by offering its shares to the general public and listing them on a stock exchange for trading. This allows the company to raise capital from investors and grants individuals and institutions the opportunity to invest in and own a portion of the company.
The life cycle of an IPO, or Initial Public Offering, begins with a company's decision to go public. It involves hiring underwriters, registering with regulatory authorities, determining the IPO price, marketing to investors, and the subscription period where investors place orders for shares. After allocation and listing, shares become publicly tradable, and the company enters the secondary market. Ongoing reporting and corporate governance are crucial as the company continues to operate as a publicly-traded entity. The IPO aims to raise capital for growth and provides investors with opportunities to trade shares in the company.
An IPO (Initial Public Offering) is when a private company goes public by selling shares to the public. Investors buy these shares, giving them ownership in the company. It's a way for companies to raise capital and expand. The process involves underwriters, regulatory filings, setting the IPO price, and marketing to investors. After the IPO, shares can be traded on a stock exchange. IPOs offer opportunities and risks, so investors should research and consider carefully.
"Upcoming IPOs" refers to initial public offerings that have been announced by private companies but have not yet occurred. These are companies that plan to go public in the near future by issuing shares to the public and listing them on a stock exchange. Investors often keep an eye on upcoming IPOs as they represent opportunities to invest in companies at their early stages of public trading, potentially capturing growth potential. These offerings are typically accompanied by significant media and investor attention as they approach their launch dates.